Details for New Drug Application (NDA): 204412
✉ Email this page to a colleague
The generic ingredient in DELZICOL is mesalamine. There are twenty-eight drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the mesalamine profile page.
Summary for 204412
Tradename: | DELZICOL |
Applicant: | Abbvie |
Ingredient: | mesalamine |
Patents: | 0 |
Suppliers and Packaging for NDA: 204412
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412 | NDA | Allergan, Inc. | 0023-5853 | 0023-5853-18 | 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0023-5853-18) |
DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412 | NDA | A-S Medication Solutions | 50090-3002 | 50090-3002-0 | 180 CAPSULE, DELAYED RELEASE in 1 BOTTLE (50090-3002-0) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED RELEASE;ORAL | Strength | 400MG | ||||
Approval Date: | Feb 1, 2013 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 204412
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription